Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07603518 · ClinicalTrials.gov registry record · Phase 1
The Pharmacokinetics of a Hemp-Based Topical Product
A Phase 1 study, sponsored by Johns Hopkins University.
- Not yet
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT07603518: Clinical Trial Phase 1 study, sponsored by Johns Hopkins University.
NCT07603518 is a Phase 1 study that has not yet begun recruiting, run by Johns Hopkins University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07603518, a Phase 1 study, has not yet begun recruiting, sponsored by Johns Hopkins University.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will evaluate the pharmacokinetic effects of acute and chronic dosing of a hemp-based cannabidiol (CBD) topical lotion with low levels of delta-9-tetrahydrocannabinol (THC) in a sanitized and controlled environment.
Interventions
- DRUG THC
- DRUG CBD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-06 |
| Est. Completion | 2026-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07603518
The ClinicalTrials.gov registry entry for NCT07603518 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which THC is the first listed.
NCT07603518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07603518 about?
NCT07603518 is a clinical study titled "The Pharmacokinetics of a Hemp-Based Topical Product". This study will evaluate the pharmacokinetic effects of acute and chronic dosing of a hemp-based cannabidiol (CBD) topical lotion with low levels of delta-9-tetrahydrocannabinol (THC) in a sanitized and controlled environment.
What is the current status of trial NCT07603518?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2026-06. Estimated completion is 2026-09.
What interventions are being tested in trial NCT07603518?
The interventions under investigation include: THC (DRUG), CBD (DRUG).
Who is sponsoring clinical trial NCT07603518?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.